VCYT Logo

Veracyte, Inc. (VCYT) 

NASDAQ
Market Cap
$3.33B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
946 of 971
Rank in Industry
540 of 557

Largest Insider Buys in Sector

VCYT Stock Price History Chart

VCYT Stock Performance

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Insider Activity of Veracyte, Inc.

Over the last 12 months, insiders at Veracyte, Inc. have bought $0 and sold $6M worth of Veracyte, Inc. stock.

On average, over the past 5 years, insiders at Veracyte, Inc. have bought $525,242 and sold $43.59M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 60,000 shares for transaction amount of $980,094 was made by Stapley Marc (Chief Executive Officer) on 2022‑06‑10.

List of Insider Buy and Sell Transactions, Veracyte, Inc.

2024-11-27SaleVP, Chief Accounting Officer
5,032
0.0065%
$42.89$215,834+0.14%
2024-11-19Saledirector
14,731
0.0188%
$38.34$564,768-0.33%
2024-11-12SaleChief Financial Officer
15,275
0.0198%
$38.34$585,663+3.53%
2024-11-12Saledirector
15,000
0.0195%
$38.32$574,830+3.53%
2024-09-19Saledirector
5,173
0.0067%
$35.23$182,263-2.38%
2024-09-04SaleChief Commercial Officer-CLIA
5,479
0.0072%
$29.78$163,159+16.02%
2024-08-13Saledirector
24,326
0.0341%
$32.04$779,456+6.20%
2024-08-13Saledirector
47,645
0.0671%
$32.20$1.53M0.00%
2024-08-12Saledirector
200
0.0003%
$30.00$6,001+13.08%
2024-08-09Saledirector
1,778
0.0024%
$30.03$53,391+15.48%
2024-08-07Saledirector
5,108
0.0075%
$30.32$154,883+24.84%
2024-08-07Saledirector
5,000
0.007%
$29.00$145,000+24.84%
2024-07-16SaleChief Commercial Officer-CLIA
1,277
0.0019%
$25.00$31,925+29.58%
2024-07-16Saledirector
7,500
0.0109%
$25.00$187,500+29.58%
2024-07-16Saledirector
5,000
0.0071%
$24.50$122,500+29.58%
2024-06-11Saledirector
3,870
0.0049%
$20.59$79,683+51.71%
2024-06-10Saledirector
3,870
0.0049%
$20.32$78,634+54.55%
2024-06-07Saledirector
2,500
0.0033%
$20.97$52,425+55.62%
2024-05-28Saledirector
1,539
0.002%
$21.00$32,319+48.21%
2024-04-01Saledirector
10,000
0.0133%
$21.65$216,528+9.70%

Insider Historical Profitability

5.66%
Chambers RebeccaChief Financial Officer
124501
0.1606%
$42.9501
Leite JohnChief Commercial Officer-CLIA
76174
0.0983%
$42.9502
EPSTEIN ROBERT Sdirector
44598
0.0575%
$42.9502
Wygant JonathanVP, Chief Accounting Officer
42313
0.0546%
$42.9501
Holstein Jensdirector
27878
0.036%
$42.9513+12.01%
Bhanji Munadirector
23105
0.0298%
$42.9504
EASTHAM KARINdirector
18497
0.0239%
$42.95012
JONES EVAN/ FAdirector
0
0%
$42.95043
Stapley MarcChief Executive Officer
159761
0.2061%
$42.9510+45.22%
Kennedy KeithCOO / CFO
119632
0.1544%
$42.9508
Hanna John Walter JRChief Commercial Officer
74309
0.0959%
$42.95014
Kennedy Giulia CChief Scientific & Med Officer
65970
0.0851%
$42.95029
Anderson Bonnie Hdirector
42681
0.0551%
$42.95451+38.63%
BISHOP JOHN Ldirector
33125
0.0427%
$42.9502
Hall Christopher MPresident and COO
28714
0.0371%
$42.95016
Ho Mark
19086
0.0246%
$42.9501
GORDON KEVIN K
8720
0.0113%
$42.9503
Brooks JulieEVP,General Counsel, Secretary
3122
0.004%
$42.9540<0.0001%
TREU JESSE Idirector
0
0%
$42.9506
Cohen Fred Edirector
0
0%
$42.9501
Guyer Shelly DChief Financial Officer
0
0%
$42.9503

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$163.65M9.667.38M+3.75%+$5.91M<0.01
Wellington Management Company$163.26M9.647.37M+4.23%+$6.63M0.03
BlackRock$159.8M9.437.21M+0.69%+$1.1M<0.01
ARK Investment Management LLC$156.07M9.217.04M-8.01%-$13.58M0.54
State Street$95.89M5.664.33M+39.19%+$27M<0.01
Dimensional Fund Advisors$76.79M4.533.47M+2.75%+$2.05M0.02
Nikko Asset Management Americas Inc$74.01M4.383.35M+7.82%+$5.37M0.55
Sumitomo Mitsui Trust Holdings$74.18M4.383.35M+7.82%+$5.38M0.05
Artisan Partners$68.25M4.033.08M-4.29%-$3.06M0.1
Champlain Investment Partners, LLC$59.78M3.532.7M+23.28%+$11.29M0.34
Arrowmark Colorado Holdings Llc$58.57M3.462.64M+5.01%+$2.79M0.15
Geode Capital Management$37.68M2.221.7M+5.17%+$1.85M<0.01
Bank of America$33.71M1.991.52M+81.22%+$15.11M<0.01
GW&K Investment Management$30.93M1.831.4M-1.39%-$434,744.460.27
Bamco$24.73M1.461.12M+46.28%+$7.82M0.07
Nuveen$22.77M1.341.03M+0.5%+$114,079.680.01
Goldman Sachs$21.65M1.28977,089-19.64%-$5.29M<0.01
Northern Trust$21.42M1.26966,482-1.36%-$295,060.40<0.01
Granite Investment Partners Llc$20.29M1.2915,750+4.87%+$941,777.840.77
Fisher Asset Management Llc$19.56M1.15882,467+0.83%+$161,900.950.01
New York State Common Retirement Fund$19.11M1.13862,583+3%+$556,575.240.03
Casdin Capital$19.01M1.12857,904New+$19.01M0.94
William Blair Investment Management$16.43M0.97741,651+0.89%+$145,679.840.04
Charles Schwab$16.24M0.96732,775+4.92%+$761,351.12<0.01
Oberweis Asset Management Inc$14.88M0.88671,700+2.27%+$329,962.401.08
Candriam S C A$14.87M0.88670,937+9.82%+$1.33M0.1
Fiera Capital$13.7M0.81618,317-3.13%-$442,823.260.04
Eventide Asset Management$12.5M0.74564,0000%+$00.2
Legal & General$11.77M0.7530,935+42.27%+$3.5M<0.01
Morgan Stanley$11.18M0.66504,620-14.72%-$1.93M<0.01
Renaissance Technologies$10.86M0.64489,900+513.14%+$9.09M0.02
Man Group Plc$10.43M0.62470,648+8.96%+$857,724.900.03
Mirae Asset Global Investments Co Ltd$9.61M0.61465,992+66.39%+$3.83M0.01
JENNISON ASSOCIATES LLC$9.12M0.54411,540+4.42%+$386,160.270.01
Invesco$7.94M0.47358,374+8.81%+$643,304.81<0.01
Granahan Investment Management$7.58M0.45342,264-32.08%-$3.58M0.27
Qube Research & Technologies$7.59M0.45342,417+158.15%+$4.65M0.01
Segall Bryant & Hamill$7.18M0.42323,926+18.73%+$1.13M0.14
Rafferty Asset Management Llc$6.84M0.4308,559+93.5%+$3.3M0.02
Silverarc Capital Management Llc$6.22M0.37280,773+13.34%+$732,388.040.06
Citigroup$6.06M0.36273,408+257.04%+$4.36M<0.01
Nordea Investment Management Ab$6.05M0.36272,176+232.27%+$4.23M0.01
Duquesne Family Office Llc$5.76M0.34259,944New+$5.76M0.16
Efg Asset Management North America Corp$5.69M0.34257,388+12.08%+$613,785.700.99
Parkman Healthcare Partners Llc$5.63M0.33254,092+7.07%+$371,756.180.7
BNY Mellon$5.54M0.33250,197-14.18%-$916,359.24<0.01
UBS$5.26M0.31237,148+39.82%+$1.5M<0.01
Voloridge Investment Management, LLC$4.77M0.28215,215New+$4.77M0.02
AMI Asset Management Corp.$4.51M0.27203,723+7.17%+$301,819.490.23
Franklin Templeton Investments$4.5M0.27202,966+465.25%+$3.7M<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.